GPX3 and atrial fibrillation: Pastori et al. demonstrated that a decrease in GPX3 with age increases the risk of cardiovascular events in individuals with AF, indicating that decreased GPX3 activity may serve as a predictor of both fatal and nonfatal cardiovascular complications [98].